DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lencioni R, Montal R, Torres F. , et al.
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC.
J Hepatol 2017;
66 (06) 1166-1172
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.